FDA Letter API

MistVapor USA

Letter data

Company
MistVapor USA
Recipient
MistVapor USA | United States | service@mistvapor.com
Issue date
2020-11-02
Posted date
Not available
FDA office
Office of Compliance and Enforcement
Subject
Not available
Product
Tobacco
CMS ID
610014
Reference number
RW2001407
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER MistVapor USA MARCS-CMS 610014 — November 02, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Reference #: RW2001407 Product: Tobacco Recipient: MistVapor USA United States service@mistvapor.com Issuing Office: Office of Compliance and Enforcement United States Dear Sir or Madam: The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions in response to our Warning Letter dated August 14, 2020. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://mistvapor.com. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future. Sincerely, /S/ David Rice Branch Chief Division of Promotion, Advertising, and Labeling Office of Compliance and Enforcement Center for Tobacco Products Content current as of: 12/01/2020 Regulated Product(s) Tobacco